Detalhe da pesquisa
1.
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).
Ann Hematol
; 99(1): 157-165, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844931
2.
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002-2018 Empirical/Pre-emptive Approach.
Mycopathologia
; 185(4): 639-652, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564177
3.
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
Eur J Haematol
; 102(5): 389-394, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719772
4.
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Lancet Oncol
; 18(2): 241-250, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956157
5.
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
Haematologica
; 102(6): 1099-1104, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28255016
6.
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?
Blood
; 124(12): 1887-93, 2014 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25102853
7.
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.
Br J Haematol
; 170(6): 804-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25974382
8.
Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.
Haematologica
; 100(9): 1207-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069291
9.
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.
Blood
; 120(8): 1589-96, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22791289
10.
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
Blood
; 120(13): 2581-8, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889759
11.
Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.
Mediators Inflamm
; 2014: 620682, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24623962
12.
Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.
Biol Blood Marrow Transplant
; 19(3): 435-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23178634
13.
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease.
Haematologica
; 97(4): 616-21, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058223
14.
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges.
Transplant Cell Ther
; 28(1): 43.e1-43.e5, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34757054
15.
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.
Transplant Cell Ther
; 28(5): 258.e1-258.e8, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131486
16.
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas.
Clin Lymphoma Myeloma Leuk
; 22(8): 635-642, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610120
17.
Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma.
Leuk Lymphoma
; 62(1): 125-135, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933355
18.
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
Bone Marrow Transplant
; 56(12): 2904-2910, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404917
19.
Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.
Blood
; 112(10): 4337-42, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18772453
20.
Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment.
Biol Blood Marrow Transplant
; 14(8): 880-7, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18640571